Please login to the form below

Not currently logged in
Email:
Password:

FlowMetric Diagnostics names president

Amy Williams has over 25 years of experience in life sciences

FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president.

Williams has over 25 years of experience in the life science industry. Prior to joining FlowMetric Diagnostics, Williams was president of SageWorks Rx, a consulting company to the life science industry.

Commenting on her appointment, she said: “I am pleased and excited to be given this opportunity to lead FlowMetric Diagnostics.

“It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and patients.”

Williams has held a variety of commercial leadership roles at Merck and Endo Pharmaceuticals and also has expertise in marketing, sales and reimbursement. She has additionally helped launch new products and indications, creating and implementing contract reimbursement strategies.

Ren Capocasale, chairman of the board, FlowMetric Diagnostics and CEO and founder of parent company Flowmetric Inc, added: “Amy brings a wealth of experience to support our business and commercialisation initiatives and will play a pivotal role in leading and executing our business strategy now and in the years ahead.”

Williams will also join the company's board of directors.

17th December 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics